By The RX Index Team ·
Medicare GLP-1 Bridge Program Application Process: Step by Step
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
Bottom line up front
The Medicare GLP-1 Bridge Program application process does not start with a patient form. Your doctor submits a prior authorization request and a prescription to a CMS-contracted central processor (Humana) — not to your Medicare Part D plan. If approved, you pay $50 a month at the pharmacy for Wegovy (injection or tablets), Zepbound KwikPen, or Foundayo (orforglipron). The program opens July 1, 2026 and runs through December 31, 2027 (extended April 21, 2026).
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We are not affiliated with CMS, Medicare, Humana, Novo Nordisk, or Eli Lilly.
What we actually verified for this guide
| Fact | Source | Status |
|---|---|---|
| Bridge runs July 1, 2026 – December 31, 2027 | CMS Medicare GLP-1 Bridge page, updated April 2026 | ✅ Verified |
| Program operates outside Part D payment flow | CMS FAQ | ✅ Verified |
| Central processor: Humana (via LI NET infrastructure) | CMS FAQ | ✅ Verified |
| Eligible drugs: Foundayo, Wegovy injection, Wegovy tablets, Zepbound KwikPen | CMS, updated April 6, 2026 | ✅ Verified |
| Three BMI/diagnosis eligibility tiers | CMS FAQ | ✅ Verified |
| BMI measured at GLP-1 therapy initiation | CMS FAQ | ✅ Verified |
| $50 monthly copay | CMS FAQ | ✅ Verified |
| $50 does NOT count toward Part D out-of-pocket cap | CMS FAQ | ✅ Verified |
| Low-Income Subsidy (Extra Help) does NOT reduce the $50 | CMS FAQ | ✅ Verified |
| Coupons and discount programs not allowed on Bridge claims | CMS FAQ | ✅ Verified |
| BIN/PCN: 028918 / MEDDGLP1BR | CMS Bridge Payer Sheet | ✅ Verified |
| Net manufacturer price: $245 / month | CMS FAQ; Avalere | ✅ Verified |
| Bridge extended through 2027; BALANCE Part D not launching in 2027 | CMS memo, April 21, 2026 | ✅ Verified |
| Exact PA submission portal and decision timeline | CMS to publish in Spring 2026 | ⏳ Pending |
| Bridge-specific appeal process | CMS to publish in Spring 2026 | ⏳ Pending |
The Medicare GLP-1 Bridge application process at a glance
Here’s the entire process on one screen, in the order you’ll do it.
| Step | What happens | Who does it | When |
|---|---|---|---|
| 1 | Confirm your Medicare Part D plan type is eligible | You | Today, 5 minutes |
| 2 | Self-check the three eligibility tiers | You | Today, 10 minutes |
| 3 | Gather documentation of BMI history and qualifying conditions | You | This week |
| 4 | Book a doctor's visit and bring the cheat sheet | You | 1–3 weeks out |
| 5 | Doctor submits the prior authorization + prescription to the CMS central processor (Humana) | Your prescriber | On or after July 1, 2026 |
| 6 | Pharmacy bills the central processor using BIN 028918 / PCN MEDDGLP1BR; you pay $50 | The pharmacy | At first fill |
| 7 | Refill monthly | You + pharmacy | Ongoing through Dec 31, 2027 |
Free. No email required. Personalized action plan for Bridge, Part D, and cash-pay alternatives.
Why “application process” is the wrong phrase — and what’s actually happening
Most government health benefits do involve a patient form. So when people search for the “Medicare GLP-1 Bridge Program application process,” they’re looking for something they fill out and submit. Here’s the truth that almost no other page tells you cleanly: as of CMS’s most recent guidance (April 2026), there is no patient form, no patient portal, and no patient submission.
The honest part most pages skip
The Bridge runs through your provider’s office, not a patient portal. If your doctor’s staff is unfamiliar with the new central-processor flow — and many will be in May and June 2026 — the whole thing stalls. CMS hasn’t published the prescriber-facing portal or the exact submission steps yet (expected this spring). Your real job between now and your first fill isn’t to find a form. It’s to make sure your doctor’s office is ready.
| What YOU do | What your DOCTOR does |
|---|---|
| Confirm you have an eligible Medicare Part D plan for 2026 | Confirms you meet one of the three CMS eligibility tiers |
| Verify your BMI history and qualifying conditions | Submits the prior authorization to the CMS central processor (Humana) |
| Bring documentation to the appointment | Submits the prescription for Wegovy, Zepbound KwikPen, or Foundayo |
| Pick up the prescription and pay the $50 copay | Attests to the lifestyle modification combination requirement |
| Re-verify each year during open enrollment | Re-submits the PA at the appropriate cadence |
Is my Medicare Part D plan eligible for the Bridge?
To use the Medicare GLP-1 Bridge, you must be enrolled in Medicare Part D for 2026 — either a standalone Prescription Drug Plan (PDP), a Medicare Advantage plan that includes drug coverage (MA-PD), a Special Needs Plan (SNP), an employer/union group waiver plan (EGWP), or LI NET.
| Your plan type | Bridge eligible? | What to do |
|---|---|---|
| Standalone Prescription Drug Plan (PDP) | ✅ Yes | Proceed to the next step |
| Medicare Advantage with drug coverage — HMO, HMO-POS, Local PPO, Regional PPO | ✅ Yes | Proceed to the next step |
| Special Needs Plans (SNPs — all types) | ✅ Yes | Proceed to the next step |
| Employer/Union Group Waiver Plans (EGWPs) | ✅ Yes | Proceed to the next step |
| Limited Income Newly Eligible Transition (LI NET) | ✅ Yes | Proceed to the next step |
| Dual-eligible (Medicare + Medicaid) in an eligible Part D plan | ✅ Yes | Proceed; note that Extra Help does NOT reduce the $50 |
| Private Fee-for-Service (PFFS) without a standalone PDP | ❌ No | Enroll in a PDP during open enrollment |
| Section 1876 cost contract plans | ❌ No | Enroll in a PDP during open enrollment (unless also in a PDP) |
| Section 1833 health care prepayment plans | ❌ No | Enroll in a PDP during open enrollment (unless also in a PDP) |
| PACE organizations | ❌ No | ⚠ Talk to your PACE organization first — see warning below |
| Fallback plans | ❌ No | Enroll in a PDP during open enrollment (unless also in a PDP) |
| Religious fraternal benefit plans | ❌ No | Enroll in a PDP during open enrollment (unless also in a PDP) |
| Original Medicare without any drug coverage | ❌ No | Enroll in Part D first |
Important warning if you’re in PACE
Do not simply enroll in a separate Part D plan to access the Bridge. According to Medicare.gov, joining a separate Medicare drug plan while in PACE will disenroll you from PACE entirely. If you’re a PACE participant, contact your PACE organization, your local SHIP counselor, or 1-800-MEDICARE first to discuss your options.
How to verify your plan type in 60 seconds
- •Look at your insurance card — “PDP,” “MA-PD,” or “SNP” is usually printed on the front.
- •Sign in at Medicare.gov, click “View my plan” — the plan type is listed.
- •Call 1-800-MEDICARE (1-800-633-4227) and ask: “Is my current plan eligible for the Medicare GLP-1 Bridge demonstration starting July 1, 2026?”
Free. No email required. Personalized action plan for Bridge, Part D, and cash-pay alternatives.
Do I qualify clinically? The three eligibility tiers
The Medicare GLP-1 Bridge has three eligibility tiers. You only need to meet one. All three are measured at the time GLP-1 therapy began — not necessarily today.
| Tier | BMI requirement | Required co-condition |
|---|---|---|
| Tier 1 | ≥ 35 | None — BMI alone qualifies |
| Tier 2 | ≥ 30 | ANY ONE of: heart failure with preserved ejection fraction (HFpEF); uncontrolled hypertension (systolic > 140 OR diastolic > 90 while on two antihypertensive medications); chronic kidney disease stage 3a or above |
| Tier 3 | ≥ 27 | ANY ONE of: prediabetes per ADA criteria (fasting glucose 100–125 mg/dL OR A1C 5.7%–6.4% OR 2-hour OGTT 140–199 mg/dL); prior myocardial infarction; prior stroke; symptomatic peripheral artery disease |
Source: CMS Medicare GLP-1 Bridge FAQ, verified April 25, 2026.
All three tiers also require: age 18 or older, the prescription written for weight reduction and maintenance, and “ongoing lifestyle modification including structured nutrition and physical activity consistent with the applicable FDA approved label.” CMS has not specified whether a formal lifestyle program is required — the prescriber attests the medication is prescribed in combination with structured nutrition and physical activity.
The historical-BMI rule (this is where most pages get it wrong)
If you’re already on a GLP-1 you’ve been paying for out of pocket, this is the most important paragraph on this page. Your BMI at the time you started GLP-1 therapy is what counts — not your BMI today. CMS’s own example: a beneficiary who started Wegovy in September 2024 with a BMI of 37 and now has a BMI of 34 still qualifies under Tier 1, because the prescriber attests to the historical BMI at therapy initiation. Eligibility includes beneficiaries who initiated therapy prior to enrolling in Medicare Part D and/or prior to the July 1, 2026 Bridge launch. Pull your records from when you first started — that visit note is gold.
What “uncontrolled hypertension” actually means here
The CMS definition is systolic blood pressure above 140 mm Hg or diastolic above 90 mm Hg while you’re already on two antihypertensive medications. One blood-pressure med plus high readings is not the same thing. If you’re at the borderline, talk to your prescriber about whether the Tier 2 attestation is supportable.
What “prediabetes per ADA criteria” actually means
The American Diabetes Association defines prediabetes as fasting plasma glucose 100–125 mg/dL, OR A1C 5.7%–6.4%, OR 2-hour oral glucose tolerance test 140–199 mg/dL. Bring your most recent labs — within the past 12 months is best.
What if your GLP-1 is for diabetes, sleep apnea, or cardiovascular disease?
Stop. The Bridge is not your lane. CMS is explicit: beneficiaries whose GLP-1 is prescribed for a use coverable under the basic Medicare Part D benefit — including Zepbound for moderate-to-severe OSA in adults with obesity, or Wegovy to reduce cardiovascular event risk in adults with established CV disease who are obese or overweight — will not qualify for coverage under the Bridge. That actually works in your favor: your Part D copay counts toward the $2,100 annual out-of-pocket cap. The Bridge $50 does not.
Bridge or Part D? The lane finder
The lane depends on why your GLP-1 is being prescribed. Same drug. Different lane. Different copay. This is the single biggest source of confusion in Medicare forums right now.
| Your situation | Correct lane | Where the PA goes | What you’ll pay |
|---|---|---|---|
| Wegovy, Zepbound KwikPen, or Foundayo for weight management + you meet a Bridge tier | Medicare GLP-1 Bridge | CMS central processor (Humana) | $50/month (does not count toward Part D OOP cap) |
| Wegovy for established cardiovascular disease + obesity/overweight | Standard Part D | Your Part D plan | Your plan’s normal cost-sharing (counts toward $2,100 cap) |
| Zepbound for moderate-to-severe obstructive sleep apnea + obesity | Standard Part D | Your Part D plan | Your plan’s normal cost-sharing (counts toward $2,100 cap) |
| Ozempic, Mounjaro, or Rybelsus for type 2 diabetes or another covered indication | Standard Part D | Your Part D plan | Subject to plan formulary, PA, and exception rules |
| Compounded semaglutide or tirzepatide formulations | Not covered | — | Out-of-pocket only; not allowed in Bridge claims |
What does the Medicare GLP-1 Bridge actually cost?
You pay $50 per monthly fill at the pharmacy. That’s the only out-of-pocket cost. But the $50 does not count toward your annual Medicare Part D deductible or your $2,100 Part D out-of-pocket maximum. Manufacturer coupons, savings cards, and the Medicare Low-Income Subsidy (Extra Help) cannot be applied to Bridge claims.
| Cost question | Bridge answer |
|---|---|
| Monthly copay | $50 |
| Does it count toward your Part D deductible? | No |
| Does it count toward the $2,100 Part D out-of-pocket cap? | No |
| Does Extra Help (LIS) reduce the $50? | No |
| Can you use a manufacturer coupon? | No |
| Can you use a GoodRx or pharmacy discount card? | No |
| Does the $50 change as you go through Part D phases? | No — stays $50 regardless |
| What does CMS pay the manufacturer? | $245 per monthly supply |
Why the $50 doesn’t count toward your $2,100 cap
The Bridge was created under Section 402 of the Social Security Amendments — a different legal authority than Part D. By design, it operates outside the Part D benefit. That means none of the Part D cost-sharing protections (deductible, $2,100 OOP cap, donut-hole rules, Extra Help subsidies) apply to a Bridge fill. KFF flagged this twice in their 2026 briefs, noting that LIS cost-sharing subsidies will not apply in the Medicare GLP-1 Bridge — which may make participation harder for low- and modest-income beneficiaries if $50 a month is unaffordable.
If $50/month is genuinely unaffordable, your options include manufacturer patient assistance programs from Novo Nordisk or Eli Lilly (verify eligibility directly — these programs may exclude government-insurance beneficiaries), existing Part D coverage if there’s a non-obesity indication that fits, or local non-profit prescription assistance programs (your SHIP counselor at shiphelp.org can point you to in-state options).
Compared with brand list prices (Wegovy and Zepbound list above $1,000/month at most pharmacies), the $50 Bridge copay is a substantial reduction. The Bridge is the cheapest legitimate option for an eligible Medicare beneficiary.
What does my doctor submit, and where does it go?
Your prescriber submits two things electronically: a prior authorization request and a prescription. Both go to the CMS central processor administered by Humana — not to your Medicare Part D plan.
The PA contains four required attestations, paraphrased plainly from the CMS FAQ:
- 1
The prescription is for weight reduction and ongoing weight maintenance.
- 2
The patient is using the medication in combination with structured nutrition and physical activity, consistent with the FDA-approved label.
- 3
The patient is 18 or older and meets one of the three BMI/diagnosis tiers (with BMI measured at therapy initiation).
- 4
The drug being prescribed is one of the Bridge-eligible products: Foundayo, Wegovy injection, Wegovy tablets, or Zepbound KwikPen.
| PA goes to | Does NOT go to |
|---|---|
| CMS central processor administered by Humana | Aetna |
| (Even if your Part D plan happens to be Humana, the Bridge PA is a separate flow) | UnitedHealthcare |
| Cigna | |
| WellCare | |
| Your specific Humana Part D plan (Bridge runs on different infrastructure) |
CMS guidance is explicit: Part D plans are not responsible for Bridge drugs and should direct providers to the central processor if they receive Bridge prior authorization requests. If your pharmacy or your prescriber’s office tries to send the PA to your Part D plan, it will get bounced back.
What’s actually covered (and what isn’t)
The Medicare GLP-1 Bridge currently covers Wegovy (injection and tablets), Zepbound KwikPen (the multi-dose pen formulation only), and Foundayo (orforglipron). Single-dose vials and single-dose pens of Zepbound are not covered. Mounjaro, Ozempic, Rybelsus, Saxenda, and any compounded GLP-1 formulations are not covered through the Bridge.
| Drug | Manufacturer | Format | Bridge-covered? | Notes |
|---|---|---|---|---|
| Wegovy® injection | Novo Nordisk | Pre-filled pen | ✅ Yes | All formulations |
| Wegovy® oral tablet | Novo Nordisk | Once-daily pill | ✅ Yes | Approved December 2025 |
| Zepbound® KwikPen® | Eli Lilly | Multi-dose pen | ✅ Yes | KwikPen formulation only |
| Zepbound® single-dose vial | Eli Lilly | Vial | ❌ No | Not covered under the Bridge |
| Zepbound® single-dose pen | Eli Lilly | Pen | ❌ No | Not covered under the Bridge |
| Foundayo® (orforglipron) | Eli Lilly | Oral GLP-1 | ✅ Yes | Added to Bridge list April 6, 2026 |
| Mounjaro® | Eli Lilly | Injection | ❌ No | May be coverable under standard Part D for type 2 diabetes |
| Ozempic® | Novo Nordisk | Injection | ❌ No | May be coverable under standard Part D for type 2 diabetes |
| Rybelsus® | Novo Nordisk | Oral | ❌ No | May be coverable under standard Part D for type 2 diabetes |
| Saxenda® | Novo Nordisk | Injection | ❌ No | — |
| Compounded semaglutide or tirzepatide | Various 503A pharmacies | Injection or oral | ❌ No | Compounds are not allowed in Bridge claims |
What documentation do I need?
Bring these to your prescribing visit. Having them ready turns a 30-minute “what is this Bridge thing?” conversation into a 5-minute clinical confirmation.
- •2026 Part D card or MA-PD card. Some MA-PD plans use a single card — bring whatever shows your prescription drug coverage.
- •Height and weight from when you started a GLP-1. If you've ever been on one, the original visit note is ideal. If you've never been on a GLP-1, your current measured height and weight are what's needed.
- •Diagnosis records that match your tier. Tier 2 HFpEF: cardiology note or echocardiogram report. Tier 2 uncontrolled hypertension: blood pressure readings plus medication list showing two antihypertensives. Tier 2 CKD 3a+: most recent eGFR result or nephrology note. Tier 3 prediabetes: A1C or fasting glucose lab within 12 months. Tier 3 prior MI/stroke/PAD: hospital discharge summary or cardiology/vascular note.
- •Current medication list. Particularly important if you're already on a GLP-1 for a different reason — your prescriber will need to make sure the lanes don't get crossed.
- •Any prior denial letters. If your Part D plan has previously denied a GLP-1 prescription, bring the letter. It tells your prescriber what's already been tried.
- •Documentation of lifestyle modification. A nutrition counseling visit, a fitness app log, or a documented commitment plus your prescriber's clinical judgment is the standard path. CMS hasn't specified beyond the structured-nutrition-and-physical-activity language.
Free. No email required. Personalized action plan for Bridge, Part D, and cash-pay alternatives.
What should I say at the doctor’s visit?
Schedule with your primary care doctor or specialist (endocrinologist, cardiologist, or nephrologist if relevant). Bring your documentation packet. Be specific that you’re asking about the Medicare GLP-1 Bridge — not a regular Part D prior authorization — for weight management.
“I’d like to ask about the new Medicare GLP-1 Bridge program. I think I qualify under [Tier 1 / Tier 2 / Tier 3] based on my BMI of [X] and [my qualifying condition]. I brought a one-page summary your office may find helpful. The prior authorization goes to the CMS central processor — Humana, operating through the LI NET infrastructure — not to my Part D plan. The program opens July 1, 2026 and runs through December 31, 2027. Would we be able to submit on or shortly after July 1?”
What if your doctor isn’t familiar with the central-processor flow?
This will be common in May and June 2026. You have three options:
- Hand the cheat sheet to the medical assistant or nurse before the visit. Most clinical staff will read it before the doctor walks in.
- Suggest your prescriber email glp1demo@cms.hhs.gov for technical questions. CMS set this address up specifically for provider questions — no patient identifying information should be sent there.
- If your prescriber declines to engage, you may need to seek another qualified medical provider who can evaluate you and submit the Bridge PA if appropriate.
What if the pharmacy claim doesn’t process?
Bridge claims require the pharmacy to bill electronically using the program-specific BIN, PCN, and group identifiers — not your Part D plan’s billing info. If a claim rejects, the most common cause is the pharmacy submitting it through your Part D plan instead of the Bridge processor. Hand the pharmacist the Bridge billing details and ask them to re-submit.
Pharmacy billing card — print this and keep it with your Medicare card
| Field | Bridge value |
|---|---|
| Plan / Group | GLP1Bridge |
| BIN | 028918 |
| PCN | MEDDGLP1BR |
| Processor | SS&C Health, routed through RelayHealth |
| Help desk | 844-673-0910 |
| Effective date | July 1, 2026 |
| Compounds | Not allowed |
| Paper claims | Not accepted |
Source: CMS Medicare GLP-1 Bridge payer sheet, dated March 16, 2026. Verify against the current CMS payer sheet before your first fill.
What if I don’t qualify, can’t wait, or my doctor won’t help?
Most readers who don’t qualify fall into one of three buckets, each with a real path.
Path 1 — Switch Part D plans during open enrollment (Oct 15 – Dec 7, 2026)
If your current plan type is excluded (PFFS without a PDP, fallback plans, religious fraternal benefit plans), your fix is enrolling in a standalone PDP or an MA-PD during open enrollment. Compare plans at Medicare.gov or call 1-800-MEDICARE for free help. SHIP counselors are available in every state and don’t sell anything. (Reminder: if you’re in PACE, do not enroll in a separate Part D plan without first contacting your PACE organization.)
Path 2 — If you have a Medicare-covered condition, you may already be in a better lane
Type 2 diabetes, established cardiovascular disease (with obesity or overweight), and moderate-to-severe sleep apnea (with obesity) are all Part-D-coverable indications. Your Part D plan handles the prior authorization, your Part D copay applies, and — critically — your copay counts toward the $2,100 annual Part D out-of-pocket cap. The Bridge $50 doesn’t. For a substantial number of older adults with metabolic conditions, the Part D lane is actually the better deal.
Path 3 — Cash-pay telehealth access to FDA-approved GLP-1 medications
If you can’t wait until July 1, 2026, your prescriber refuses to engage with the Bridge, or you simply don’t qualify and want to start treatment now, Ro is a legitimate cash-pay path for FDA-approved Wegovy (pill or pen), Zepbound KwikPen, and Foundayo.
Ro Body — for non-qualifiers and pre-July 2026 starters
| Item | Verified detail (April 25, 2026) |
|---|---|
| First month | $39 |
| Ongoing monthly | $149/month or as low as $74/month with annual prepay |
| Medication cost | Billed separately at branded list / negotiated pricing |
| FDA-approved formulary | Wegovy pill, Wegovy pen, Zepbound KwikPen, Foundayo |
| Government insurance coordination | Not currently available |
| Compounded medications as substitutes | No |
Ro is the right fit if: you’re not yet on Medicare (under 65 or in a transition period), your plan type is excluded from the Bridge, you want to start a few weeks early (May or June 2026), or your prescriber won’t engage with the central-processor flow.
Ro is not the right fit if: you qualify for the Bridge (the Bridge wins on cost — $50/month vs. Ro’s $149/month membership plus medication), you have type 2 diabetes and need a GLP-1 (Part D is your lane), or you want Medicare coverage coordination (Ro can’t coordinate with Medicare).
Disclosure: The RX Index may earn a commission. This does not affect the CMS eligibility criteria or drug list on this page.
Path 3b — Sesame Care (secondary cash-pay option)
Sesame Care offers the broadest branded formulary among cash-pay platforms (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, Saxenda) and Costco-member pricing on some branded GLP-1s. Best fit for Costco members and value-conscious self-pay shoppers who want a transactional, single-visit model. Like Ro, Sesame does not coordinate with Medicare for GLP-1 weight-management coverage.
What real Medicare beneficiaries are confused about
The Bridge hasn’t launched yet, so no one is technically a “Bridge enrollee.” But Medicare-focused forums are already loaded with the questions and frustrations the Bridge is supposed to fix. Here are three patterns we see repeatedly, paraphrased to protect privacy.
"We appealed the Part D denial and I still got rejected — I'm devastated."
This is exactly the kind of denial the Bridge is designed to bypass. Standard Part D denies weight-loss prescriptions because federal law has prohibited Medicare from covering obesity drugs since 2003. The Bridge is a separate program that only covers weight-loss use, and it doesn't go through your Part D plan at all. If you've been denied by Part D for weight-loss use, that's not the end — that's the wrong lane. Your prescriber needs to submit to the Bridge central processor instead.
"Good luck convincing your doctor's office to do the legwork on this."
This is real and worth taking seriously. Some practices won't engage with new prior-authorization workflows in the first months. The one-page cheat sheet is designed for exactly this — it's something your prescriber's MA can read in 90 seconds. If your prescriber genuinely refuses to engage, switching to a practice familiar with the Bridge workflow may be the path of least resistance.
"The Bridge program isn't really insurance coverage."
Half right. The Bridge isn't your Part D plan — it's a separate CMS demonstration that operates outside the Part D benefit. But it's still a real CMS-administered benefit, paid for by Medicare, with $50 fills at any pharmacy that bills correctly. It's not a coupon, not a manufacturer assistance program, and not a discount card. It's a federal program. The confusion exists because the architecture is genuinely unusual — and that's why this page exists.
What changes after December 31, 2027?
The Bridge currently sunsets on December 31, 2027. The original plan was for the BALANCE Model to take over Medicare Part D coverage of GLP-1s for obesity starting January 1, 2027. On April 21, 2026, CMS announced that the Part D portion of BALANCE is not launching in 2027, and future Part D implementation is uncertain. As of now there is no confirmed permanent successor to the Bridge after 2027.
| Date | What happens |
|---|---|
| Today (April 25, 2026) | Verify your eligibility, gather documentation, book your appointment |
| Spring 2026 | CMS expected to publish detailed PA submission guidance and the appeal process |
| July 1, 2026 | Bridge opens; first prior authorizations submitted; first prescriptions filled at $50 |
| October 15 – December 7, 2026 | Open enrollment for 2027 — verify your plan is still eligible |
| December 31, 2027 | Current Bridge sunset date |
| Early 2028 | CMS publishes the CY2028 Advance Notice — first official signal of what comes next |
The Bridge gives you 18 months of certainty (July 2026 through December 2027). After that, the path depends on whether CMS launches a successor program, whether manufacturers maintain their negotiated pricing, or whether Congress acts on broader obesity-coverage legislation. Plan your treatment with that uncertainty in mind, but don’t panic about it. Eighteen months is plenty of runway.
Frequently Asked Questions
How do I apply for the Medicare GLP-1 Bridge Program?
Is there a Medicare GLP-1 Bridge application form?
When does the Medicare GLP-1 Bridge start?
Does my doctor have to be enrolled in Medicare to submit the Bridge PA?
Do pharmacies need to opt in to the Medicare GLP-1 Bridge?
How long is prior authorization good for under the Bridge?
Does the Medicare GLP-1 Bridge cover Ozempic or Mounjaro?
What do the BIN and PCN numbers mean for the Bridge?
Who is the central processor for the Medicare GLP-1 Bridge?
Does the $50 copay count toward my Medicare Part D out-of-pocket cap?
Does Extra Help (Low-Income Subsidy) reduce the $50 Bridge copay?
Can I use a manufacturer coupon or savings card with the Bridge?
What if I'm dual-eligible (Medicare + Medicaid)?
What if I'm on a Medicare Advantage plan without drug coverage?
What if I'm in PACE?
Will the Bridge be extended past December 31, 2027?
What if my current BMI is lower because I already lost weight on a GLP-1?
What if I'm denied?
Is the Medicare GLP-1 Bridge available in my state?
How we built this guide
This page was assembled by The RX Index Team. We reviewed and cross-checked:
- The official CMS Medicare GLP-1 Bridge program page at cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge (last CMS update: April 6, 2026)
- The CMS Medicare GLP-1 Bridge FAQ document, March 2026
- The CMS Bridge payer sheet at cms.gov/files/document/glp-1-bridge-payer-sheet.pdf
- The CMS BALANCE Model FAQ update, April 21, 2026
- KFF policy briefs from March and April 2026 ("What to Know About the BALANCE Model" and "CMS Extends Medicare's Short-Term Bridge Program")
- The Avalere Health Advisory analysis "Bridging the Gap: The Future of GLP-1 Coverage in Part D"
- ReedSmith and AMCP regulatory analyses of the CMS FAQs
- Ro's published weight-loss program pages and FAQ for verified pricing and government-insurance policy, verified April 25, 2026
We do not pretend to be your physician, pharmacist, or Medicare insurance counselor. This page is an administrative coverage guide. Your prescriber, pharmacy, and Medicare itself are the authoritative sources for your specific situation. If you’re stuck on a complex appeal, your local SHIP counselor (shiphelp.org) provides free help — every state has one.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz — we’ll route you to the right Medicare lane, the right cash-pay alternative, or both.
Take the free 60-second Medicare GLP-1 quiz →Related guides
· By The RX Index Team · Next re-verification: quarterly and after any CMS update. This page is not medical or legal advice. The Medicare GLP-1 Bridge Program is a CMS demonstration with details subject to change. The RX Index is not affiliated with CMS, Medicare, Humana, Novo Nordisk, or Eli Lilly. If something here is out of date the day you’re reading it, please let us know and we’ll fix it within 48 hours.